Health X Platform (HEALTHX) is loss-making over the last 12 months, losing ₹20 Cr, so a P/E ratio does not apply. Its share price on 6 Nov 2026 was ₹272.55, 25% below its 52-week high. Sales grew 8.0% a year over 3 years. The company has almost no debt. It is a small-cap company with a market cap of ₹867 Cr, ranked 2nd of 8 Pharmaceutical Retailers companies by market cap; the shares fell 8.3% over the past year.
- ₹277.90
- ₹277.90
- ₹271.50
- ₹273.70
- 1.8K
Health check
- ReturnsAhead
−8.3% over a year, better than 5 of 7 peers.
- Price tagLoss-making
Earnings were negative over the last 12 months.
- GrowthUnder pressure
Sales +8.0% a year over 3 years, but loss-making now.
- ProfitabilityNegative
ROCE -0.2% vs peer median 12.2%.
- Balance sheetStretched
Practically debt-free, Piotroski 5 of 9.
- Red flags4 to check
Loss-making over the last twelve months.
Small cap
Defensive
Key metrics
- Market cap
- ₹867 Cr
- Small cap
- P/E
- n/a
- Industry 27.6
- Price to book
- 1.35
- Peers 3.47
- Dividend yield
- 0.00%
- ROE
- 0.2%
- Peers 11.5%
- ROCE
- −0.2%
- Peers 12.2%
- Debt to equity
- 0.03
- Debt ₹26 Cr
- EPS (TTM)
- −₹6.35
- Face value ₹10
- OPM (TTM)
- −4.4%
- Net margin −1.3%
- Sales growth
- +58.0%
- Latest quarter vs a year ago
- Profit growth
- −89.4%
- Latest quarter vs a year ago
- Price to sales
- 0.57
- EV/EBITDA −46.4
Strengths and risks
Strengths
- Practically debt-free.
- Quarterly sales up 58.0% on a year ago.
Risks to check
- Loss-making over the last twelve months.
- Return on equity is low at 0.2%.
- Quarterly profit down 89.4% on a year ago.
- Interest coverage of only −82.8×.
About Health X Platform
Health X Platform Limited operates a digital network of healthcare and portfolio management services in India. The company operates through the Financial Services, Healthcare Network, and Others segments. It is involved in the financing of loans; investment in shares and securities; and activities for pathology, and trading and distribution of healthcare and OTC products through e-commerce portal. The company also provides financial consultancy,…
- Headquarters
- Kolkata
- Employees
- 2,760
- Sector
- Healthcare
- ISIN
- INE019J01013
- Website
- healthxplatform.com
Price range
- Avg volume (3M)
- 6.3K
- 1-year return
- minus 8.3%
- From 52-week high
- minus 24.9%
Peers · Pharmaceutical Retailers
| Company | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MEDPLUSMedplus Health Services | 604.60 | plus 0.66% | 7,260 | 34.3 | 3.47 | 12.2% | 10.8% | 4.2% | 14.7% | 64.0% | 0.00% | minus 25.7% |
| HEALTHXHealth X Platform | 272.55 | minus 0.42% | 867 | – | 1.35 | −0.2% | 0.2% | −4.4% | 8.0% | – | 0.00% | minus 8.3% |
| ONEGLOBALOne Global Service Provider | 365.45 | minus 7.66% | 714 | 9.7 | 5.06 | 65.7% | 65.3% | 19.2% | 201.8% | 269.3% | 0.23% | minus 32.0% |
| TLLTrident Lifeline | 413.75 | minus 2.07% | 495 | 21.0 | 4.22 | 21.8% | 23.6% | 22.8% | 59.7% | 46.8% | 0.24% | plus 40.8% |
| ACHYUTAchyut Healthcare | 7.76 | plus 4.86% | 187 | 776.0 | 5.45 | 1.1% | 1.0% | 2.2% | 62.6% | 10.9% | 0.00% | plus 28.7% |
| MAITRIMaitri Enterprises | 31.20 | plus 0.32% | 14 | 37.6 | 2.61 | 19.9% | 12.1% | 5.4% | 35.8% | – | 0.00% | minus 11.4% |
| MULLERMuller & Phipps (India) | 193.80 | plus 3.11% | 12 | – | −5.82 | 1.8% | – | −17.2% | 12.9% | – | 0.00% | minus 23.9% |
| DPLDipna Pharmachem | 4.31 | plus 1.65% | 11 | 10.5 | 0.18 | 5.2% | 5.2% | 21.2% | 7.7% | 2.2% | 0.00% | minus 78.4% |
| Median of 7 peers | – | 0.66% | 187 | 27.6 | 3.47 | 12.2% | 11.5% | 5.4% | 35.8% | 46.8% | 0.00% | −23.9% |
Quarterly results
| ₹ Cr | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 |
|---|---|---|---|---|---|
| 279 | 309 | 342 | 378 | 441 | |
| 292 | 324 | 356 | 399 | 455 | |
| −13.6 | −14.9 | −14.6 | −20.6 | −14.7 | |
| −4.9% | −4.8% | −4.3% | −5.4% | −3.3% | |
| 25.4 | 5.5 | 13.6 | 13.8 | 12.8 | |
| 0.1 | 0 | 0.2 | 0.5 | 0.6 | |
| 1.2 | 1.3 | 2.2 | 1.9 | 1.9 | |
| 19.7 | −7.9 | 4.2 | −5.6 | 6.3 | |
| 30.2 | −18.6 | 0.9 | −14.8 | 2 | |
| 11.9% | 17.2% | 59.9% | 12.5% | −0.6% | |
| 23.9 | −12.7 | 1.1 | −11.2 | 2.5 | |
| 7.52 | -3.99 | 0.35 | -3.51 | 0.80 |
Profit & loss
- Sales CAGR 3Y
- +8.0%
- ROE
- 0.2%
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 1,038 | 1,356 | 1,090 | 1,308 | |
| – | +30.6% | minus 19.7% | +20.0% | |
| 1,081 | 1,370 | 1,148 | 1,369 | |
| −43.2 | −13.8 | −58.6 | −61.8 | |
| −4.2% | −1.0% | −5.4% | −4.7% | |
| −64.9 | −58.7 | 23.6 | 34.8 | |
| 0.9 | 1 | 0.2 | 0.7 | |
| 8.2 | 9.1 | 5.8 | 6.6 | |
| −5 | 52.1 | −163 | 32 | |
| −122 | −30.5 | −204 | −2.4 | |
| 18.6% | 119.2% | 34.4% | 38.6% | |
| −72.2 | 8.9 | −91.2 | 1.2 | |
| -22.70 | 2.79 | -28.66 | 0.37 |
Forecast
Balance sheet
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 31.8 | 31.8 | 31.8 | 31.8 | |
| 722 | 731 | 638 | 609 | |
| 9.3 | 3.9 | 0.9 | 25.7 | |
| 443 | 383 | 304 | 269 | |
| 1,206 | 1,150 | 974 | 936 | |
| 71.9 | 72 | 73.6 | 79.4 | |
| 3.8 | 0.4 | 10.2 | 1.2 | |
| 201 | 448 | 271 | 418 | |
| 208 | 395 | 407 | 156 | |
| 722 | 234 | 213 | 282 | |
| 1,206 | 1,150 | 974 | 936 |
Cash flow
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| −112 | 35.9 | −17.3 | −73.8 | |
| 133 | −33.9 | −1.1 | 171 | |
| −1.8 | −2.4 | −0.4 | −79.6 | |
| 18.7 | −0.4 | −18.9 | 17.8 | |
| −19.5 | −14.2 | −10.4 | −14.9 | |
| −131 | 21.6 | −27.7 | −88.8 |
Shareholding pattern
- Promoters74.07%
- Public25.93%
| Quarter | Split | Promoters | Public | Promoter change |
|---|---|---|---|---|
| 30 Sep 2026 | 74.07% | 25.93% | 0.00 | |
| 30 Jun 2026 | 74.07% | 25.93% | minus 0.77 | |
| 31 Mar 2026 | 74.84% | 25.16% | plus 0.15 | |
| 31 Dec 2025 | 74.69% | 25.31% | plus 0.45 | |
| 30 Sep 2025 | 74.24% | 25.76% | – |
Major shareholders
Filings & events
News
No recent news coverage found.